152 related articles for article (PubMed ID: 38827305)
21. Safety and Immunogenicity of a Candidate Bioconjugate Vaccine against Shigella flexneri 2a Administered to Healthy Adults: a Single-Blind, Randomized Phase I Study.
Riddle MS; Kaminski RW; Di Paolo C; Porter CK; Gutierrez RL; Clarkson KA; Weerts HE; Duplessis C; Castellano A; Alaimo C; Paolino K; Gormley R; Gambillara Fonck V
Clin Vaccine Immunol; 2016 Dec; 23(12):908-917. PubMed ID: 27581434
[TBL] [Abstract][Full Text] [Related]
22. Shigellosis in Vietnam: seroepidemiologic studies with use of lipopolysaccharide antigens in enzyme immunoassays.
Lindberg AA; Cam PD; Chan N; Phu LK; Trach DD; Lindberg G; Karlsson K; Kärnell A; Ekwall E
Rev Infect Dis; 1991; 13 Suppl 4():S231-7. PubMed ID: 2047643
[TBL] [Abstract][Full Text] [Related]
23. Global burden of Shigella infections: implications for vaccine development and implementation of control strategies.
Kotloff KL; Winickoff JP; Ivanoff B; Clemens JD; Swerdlow DL; Sansonetti PJ; Adak GK; Levine MM
Bull World Health Organ; 1999; 77(8):651-66. PubMed ID: 10516787
[TBL] [Abstract][Full Text] [Related]
24. Prospective study of systemic and mucosal immune responses in dysenteric patients to specific Shigella invasion plasmid antigens and lipopolysaccharides.
Oberhelman RA; Kopecko DJ; Salazar-Lindo E; Gotuzzo E; Buysse JM; Venkatesan MM; Yi A; Fernandez-Prada C; Guzman M; León-Barúa R
Infect Immun; 1991 Jul; 59(7):2341-50. PubMed ID: 2050402
[TBL] [Abstract][Full Text] [Related]
25. Human challenge study with a Shigella bioconjugate vaccine: Analyses of clinical efficacy and correlate of protection.
Talaat KR; Alaimo C; Martin P; Bourgeois AL; Dreyer AM; Kaminski RW; Porter CK; Chakraborty S; Clarkson KA; Brubaker J; Elwood D; Frölich R; DeNearing B; Weerts H; Feijoo BL; Halpern J; Sack D; Riddle MS; Fonck VG
EBioMedicine; 2021 Apr; 66():103310. PubMed ID: 33862589
[TBL] [Abstract][Full Text] [Related]
26. Comparing invasive and non-invasive of isolated Shigella flexneri by electron microscopy of cell culture, SDS-PAGE and Congo red method.
Hakemi Vala M; Nowroozi J; Ghazi F; Nabavi Tabatabai P; Haghighi S
Iran Biomed J; 2007 Jan; 11(1):47-52. PubMed ID: 18051704
[TBL] [Abstract][Full Text] [Related]
27. Shigellosis.
Niyogi SK
J Microbiol; 2005 Apr; 43(2):133-43. PubMed ID: 15880088
[TBL] [Abstract][Full Text] [Related]
28.
Clarkson KA; Porter CK; Talaat KR; Frenck RW; Alaimo C; Martin P; Bourgeois AL; Kaminski RW
mSphere; 2021 Aug; 6(4):e0012221. PubMed ID: 34259559
[No Abstract] [Full Text] [Related]
29. Age-related efficacy of Shigella O-specific polysaccharide conjugates in 1-4-year-old Israeli children.
Passwell JH; Ashkenazi S; Banet-Levi Y; Ramon-Saraf R; Farzam N; Lerner-Geva L; Even-Nir H; Yerushalmi B; Chu C; Shiloach J; Robbins JB; Schneerson R;
Vaccine; 2010 Mar; 28(10):2231-2235. PubMed ID: 20056180
[TBL] [Abstract][Full Text] [Related]
30. Vaccination with Shigella flexneri 2a conjugate induces type 2a and cross-reactive type 6 antibodies in humans but not in mice.
Farzam N; Ramon-Saraf R; Banet-Levi Y; Lerner-Geva L; Ashkenazi S; Kubler-Kielb J; Vinogradov E; Robbins JB; Schneerson R
Vaccine; 2017 Sep; 35(37):4990-4996. PubMed ID: 28797729
[TBL] [Abstract][Full Text] [Related]
31. Surveillance of antimicrobial susceptibility patterns among Shigella species isolated in China during the 7-year period of 2005-2011.
Yang H; Chen G; Zhu Y; Liu Y; Cheng J; Hu L; Ye Y; Li J
Ann Lab Med; 2013 Mar; 33(2):111-5. PubMed ID: 23482897
[TBL] [Abstract][Full Text] [Related]
32. Cross-reactivity of Shigella flexneri serotype 2a O antigen antibodies following immunization or infection.
Van De Verg LL; Bendiuk NO; Kotloff K; Marsh MM; Ruckert JL; Puryear JL; Taylor DN; Hartman AB
Vaccine; 1996 Aug; 14(11):1062-8. PubMed ID: 8879103
[TBL] [Abstract][Full Text] [Related]
33. A broadly immunogenic polyvalent
Li S; Anvari S; Ptacek G; Upadhyay I; Kaminski RW; Sack DA; Zhang W
Infect Immun; 2023 Nov; 91(11):e0031623. PubMed ID: 37795982
[TBL] [Abstract][Full Text] [Related]
34. [Point-of-care tests for the rapid diagnosis of shigellosis].
Haddar C; Begaud E; Maslin J; Germani Y
Bull Soc Pathol Exot; 2017 Feb; 110(1):1-8. PubMed ID: 28116567
[TBL] [Abstract][Full Text] [Related]
35. Shigellosis in Calcutta during 1990-1992: antibiotic susceptibility pattern and clinical features.
Bhattacharya MK; Bhattacharya SK; Paul M; Dutta D; Dutta P; Kole H; De D; Ghosh AR; Das P; Nair GB
J Diarrhoeal Dis Res; 1994 Jun; 12(2):121-4. PubMed ID: 7963341
[TBL] [Abstract][Full Text] [Related]
36. Identification of Shigella flexneri subserotype 1c in rural Egypt.
El-Gendy A; El-Ghorab N; Lane EM; Elyazeed RA; Carlin NI; Mitry MM; Kay BA; Savarino SJ; Peruski LF
J Clin Microbiol; 1999 Mar; 37(3):873-4. PubMed ID: 9986881
[TBL] [Abstract][Full Text] [Related]
37. Rationalizing the design of a broad coverage Shigella vaccine based on evaluation of immunological cross-reactivity among S. flexneri serotypes.
Citiulo F; Necchi F; Mancini F; Rossi O; Aruta MG; Gasperini G; Alfini R; Rondini S; Micoli F; Rappuoli R; Saul A; Martin LB
PLoS Negl Trop Dis; 2021 Oct; 15(10):e0009826. PubMed ID: 34644291
[TBL] [Abstract][Full Text] [Related]
38. Characterization and quantitative analysis of serum IgG class and subclass response to Shigella sonnei and Shigella flexneri 2a lipopolysaccharide following natural Shigella infection.
Robin G; Cohen D; Orr N; Markus I; Slepon R; Ashkenazi S; Keisari Y
J Infect Dis; 1997 May; 175(5):1128-33. PubMed ID: 9129076
[TBL] [Abstract][Full Text] [Related]
39. Lipopolysaccharide-specific antibodies in plasma and stools of children with Shigella-associated leukemoid reaction and hemolytic-uremic syndrome.
Azim T; Qadri F; Ahmed S; Sarker MS; Halder RC; Hamadani J; Chowdhury A; Wahed MA; Salam MA; Albert MJ
Clin Diagn Lab Immunol; 1996 Nov; 3(6):701-5. PubMed ID: 8914761
[TBL] [Abstract][Full Text] [Related]
40. Monoclonal antibodies against the surface antigens of Shigella flexneri serotype 1b and Shigella dysenteriae serotype 1.
Suzuki K; Takeda T
Microbiol Immunol; 1989; 33(11):897-906. PubMed ID: 2687648
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
